secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxart, Inc. (VXRT)
CIK:        0000072444
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0001437749-25-028047
Event type: regulatory
Sentiment:  neutral
Materiality: 0.80
Item codes: 7.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Vaxart granted Nasdaq extension; must complete reverse stock split by Oct 6, regain $1 bid price by Oct 17
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel decision on Aug 27, 2025 grants continued listing with three conditions.
- Shareholder approval for reverse stock split required by Sep 5, 2025 special meeting.
- Reverse stock split must be completed by Oct 6, 2025; bid price compliance by Oct 17, 2025.
- Failure to obtain RSS approval will result in delisting per the Panel's decision.
- Vaxart engaged in stockholder outreach; management emphasizes RSS vote for Nasdaq future.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/72444/000143774925028047/0001437749-25-028047-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/72444/000143774925028047/vxrt20250829_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-028047

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer